Recent FGEN News
- Traders Rush To Buy Biotech Following Q1 Earnings Beat • AllPennyStocks.com • 05/07/2024 03:55:00 PM
- FibroGen to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2024 08:10:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 08:05:13 PM
- FibroGen Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/06/2024 08:02:00 PM
- FibroGen to Report First Quarter 2024 Financial Results • GlobeNewswire Inc. • 04/29/2024 11:00:00 AM
- FibroGen Announces Clinical Data from Dose Escalation Phase 1b Study of FG-3246 (FOR46) in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer will be Presented at the 2024 American Society of Clinical Oncology A • GlobeNewswire Inc. • 04/24/2024 08:02:00 PM
- FibroGen Announces Topline Results from Phase 1 Monotherapy Study of FG-3246 in Patients with Metastatic Castration-Resistant Prostate Cancer • GlobeNewswire Inc. • 04/02/2024 09:46:47 PM
- FibroGen to Present at 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 03/26/2024 11:00:00 AM
- FibroGen Appoints Deyaa Adib, M.D. as Chief Medical Officer • GlobeNewswire Inc. • 03/11/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 12:19:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 12:18:20 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/09/2024 12:17:01 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 09:08:13 PM
- FibroGen Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/26/2024 09:06:00 PM
- FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZeneca Territories, Except China and South Korea • GlobeNewswire Inc. • 02/26/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2024 01:33:43 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2024 01:29:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/24/2024 01:28:24 AM
- FibroGen to Report Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/20/2024 12:00:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 08:37:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/06/2024 01:08:37 AM
- FibroGen To Host Part I of Virtual KOL Investor Event Series to Review Pamrevlumab Clinical Program in Pancreatic Cancer on February 13, 2024 • GlobeNewswire Inc. • 02/05/2024 12:00:00 PM
- FibroGen Announces Completion of the Pamrevlumab Arm in Precision Promise, Pancreatic Cancer Action Network’s Phase 2/3 Adaptive Platform Trial for Metastatic Pancreatic Cancer • GlobeNewswire Inc. • 01/25/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/27/2023 12:28:47 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM